DUBLIN--(BUSINESS WIRE)--The "Extracorporeal Membrane Oxygenation Machine Market by Modality, Application and Region - Analysis & Forecasts to 2021" report has been added to Research and Markets' offering.
The global extracorporeal membrane oxygenation (ECMO) machine market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%.
The global market is segmented on the basis of modality, application, and region. By modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is accounted for the largest share of the market in 2016. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, increasing incidence of COPD, and technological advancements. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the forecast period.
A majority of the leading players in the market is focusing on approvals, product launches, agreements, partnerships, expansions, and acquisitions to expand their product portfolios and customer bases, enhance their sales channels, and increase their global presence.
- Alung Technologies, Inc.
- Eurosets S.R.L.
- Getinge Group
- Livanova PLC
- Medtronic PLC
- Microport Scientific Corporation
- Nipro Corporation
- Origen Biomedical, Inc.
- Terumo Corporation
- Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Extracorporeal Membrane Oxygenation Machine Market, By Modality
7 Global Extracorporeal Membrane Oxygenation Machine Market, By Application
8 Extracorporeal Membrane Oxygenation Machine Market, By Region
9 Competitive Landscape
10 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/xbhk7j/extracorporeal